Kirk R Schultz Selected Research

2-amino-4-phenylbutyric acid

4/2012

Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kirk R Schultz Research Topics

Disease

28	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021 - 01/2002
26	Leukemia 10/2022 - 12/2003
26	Bronchiolitis Obliterans Syndrome 05/2022 - 09/2004
25	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 01/2002
17	Neoplasms (Cancer) 01/2020 - 05/2003
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2021 - 12/2009
7	Hematologic Neoplasms (Hematological Malignancy) 10/2021 - 11/2010
7	Residual Neoplasm 01/2021 - 11/2009
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 07/2004
6	Infections 01/2020 - 11/2004
5	Philadelphia Chromosome 01/2021 - 11/2009
4	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 09/2011
4	Inflammation (Inflammations) 01/2020 - 06/2015
4	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2013 - 09/2004
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 11/2010
3	Lymphoma (Lymphomas) 01/2020 - 09/2017
2	Kidney Diseases (Kidney Disease) 01/2022 - 01/2020
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2020
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2020 - 02/2010
2	Neuroblastoma 01/2020 - 02/2008
2	Neutropenia 02/2018 - 03/2013
2	Bone Marrow Failure Disorders 01/2018 - 10/2015
2	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 04/2006 - 12/2003
1	Hypokalemia 10/2022
1	Tumor Lysis Syndrome 10/2022
1	Mucositis 10/2022
1	Febrile Neutropenia 10/2022
1	Capillary Leak Syndrome 01/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2020
1	monosomy Chromosome 7 01/2020
1	Hepatitis 01/2020
1	Pathologic Complete Response 01/2020
1	Common Variable Immunodeficiency 01/2020
1	Wilms Tumor (Wilm's Tumor) 10/2018
1	Glycogen Storage Disease (Glycogenosis) 02/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2018
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018
1	Nijmegen Breakage Syndrome 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2006
5	Imatinib Mesylate (Gleevec)FDA Link 10/2020 - 02/2008
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2018 - 02/2007
4	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 02/2016
4	Biological ProductsIBA 09/2017 - 05/2003
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2020
3	AntigensIBA 01/2019 - 09/2012
3	Filgrastim (Neupogen)FDA Link 11/2017 - 01/2016
3	trans-crotonin (CTN)IBA 10/2017 - 08/2012
3	CytokinesIBA 12/2011 - 01/2002
2	Etoposide (VP 16)FDA LinkGeneric 10/2022 - 04/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 04/2006
2	Lipocalin-2IBA 01/2022 - 01/2017
2	CreatinineIBA 01/2022 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 10/2020 - 02/2007
2	Dasatinib (BMS 354825)FDA Link 10/2020 - 01/2018
2	HLA-A Antigens (HLA-A)IBA 01/2020 - 11/2013
2	Calcineurin InhibitorsIBA 01/2019 - 01/2018
2	SteroidsIBA 01/2019 - 11/2009
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2018 - 09/2004
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2017 - 08/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2015 - 09/2011
2	Hemoglobins (Hemoglobin)IBA 03/2013 - 09/2003
2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2011 - 11/2010
1	temsirolimus FDA Link 10/2022
1	Alanine Transaminase (SGPT)IBA 10/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2022
1	TOR Serine-Threonine KinasesIBA 10/2022
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2022
1	Abatacept (Orencia)FDA Link 10/2021
1	eltrombopag FDA Link 01/2021
1	immunotoxin HA22IBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 10/2020
1	nelarabine (506U78)FDA Link 10/2020
1	pegaspargase (Oncaspar)FDA Link 10/2020
1	HLA-B Antigens (HLA-B)IBA 01/2020
1	Phospholipase C gammaIBA 01/2020
1	Phospholipases (Phospholipase)IBA 01/2020
1	HLA-C Antigens (HLA-C)IBA 01/2020
1	ElectrolytesIBA 01/2020
1	ponatinibIBA 01/2020
1	GNKG168IBA 11/2019
1	Alemtuzumab (Campath)FDA Link 01/2019
1	B-Cell Activating FactorIBA 01/2019
1	DNA Ligase ATPIBA 01/2018
1	AntibodiesIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Blood Group Antigens (Blood Groups)IBA 01/2018
1	Methylprednisolone FDA LinkGeneric 01/2018

Therapy/Procedure

28	Cell Transplantation 01/2022 - 12/2008
26	Transplantation 10/2021 - 01/2002
21	Hematopoietic Stem Cell Transplantation 01/2022 - 12/2003
18	Therapeutics 05/2022 - 02/2006
9	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2018 - 07/2004
8	Drug Therapy (Chemotherapy) 01/2021 - 05/2003
4	Homologous Transplantation 01/2017 - 04/2006
2	Stem Cell Transplantation 01/2021 - 12/2009
1	Cranial Irradiation 01/2018